HOUSE AMENDMENT
Bill No. HB 1E CS
   
1 CHAMBER ACTION
2
Senate House
3 .
4 .
5 .
6         
7         
8         
9         
10         
11         
12          Representative Sobel offered the following:
13         
14          Amendment to Amendment (565379)
15          Remove line(s) 463-509, and insert:
16          (a) The grantee shall reinvest 15 percent of the net
17    royalty revenues and of the revenues from the sale of stock
18    received by The Scripps Research Institute from the licensing or
19    transfer of inventions, methods, processes, and other patentable
20    activities conceived or reduced to practice using facilities or
21    employees of the grantee. For purposes of this paragraph, the
22    term “net royalty revenues” means all royalty revenues less the
23    cost of obtaining, maintaining, and enforcing related patent and
24    intellectual property rights, both foreign and domestic.
25    Reinvestment payments under this subsection shall commence no
26    later than 6 months after the grantee has received the final
27    disbursement under the contract.
28          (b) The grantee shall reinvest 15 percent of the gross
29    revenues it receives from naming opportunities associated with
30    any facility it builds in this state. For purposes of this
31    paragraph, the term “naming opportunities” includes charitable
32    donations from any person in consideration for the right to have
33    all or a portion of the facility named for or in the memory of
34    any person, living or dead, or for any entity. The obligation to
35    make reinvestment payments under this subsection shall commence
36    upon the execution of the contract between the corporation and
37    the grantee.
38         
39          All public universities and private not-for-profit universities
40    in this state shall receive 75 percent of reinvestment payments
41    made pursuant to this subsection and 25 percent of such payments
42    shall be remitted to the state for deposit in the Biomedical
43    Research Trust Fund, or if such fund has ceased to exist, in
44    another trust fund that supports biomedical research, as
45    determined by law.